KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) EBITDA Margin (2016 - 2025)

Precigen (PGEN) has disclosed EBITDA Margin for 14 consecutive years, with 275.44% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 45518.0% to 275.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1393.53% through Dec 2025, up 144381.0% year-over-year, with the annual reading at 1141.13% for FY2025, 229910.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 275.44% at Precigen, up from 77473.17% in the prior quarter.
  • The five-year high for EBITDA Margin was 217.05% in Q4 2021, with the low at 2126200.0% in Q3 2024.
  • Average EBITDA Margin over 5 years is 145482.69%, with a median of 830.02% recorded in 2022.
  • Peak annual rise in EBITDA Margin hit 41391450bps in 2024, while the deepest fall reached -212458449bps in 2024.
  • Over 5 years, EBITDA Margin stood at 217.05% in 2021, then plummeted by -3116bps to 6545.65% in 2022, then skyrocketed by 90bps to 622.82% in 2023, then fell by -17bps to 730.62% in 2024, then surged by 62bps to 275.44% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 275.44%, 77473.17%, and 98243.48% for Q4 2025, Q2 2025, and Q1 2025 respectively.